ENC1 Activators
ENC1 Activators are a suite of chemical compounds that influence various intracellular signaling cascades leading to the enhancement of ENC1's functional role within neural cells. Forskolin and Dibutyryl-cAMP (db-cAMP) both operate by elevating intracellular cyclic AMP (cAMP), which activates protein kinase A (PKA) and could potentially result in the phosphorylation of ENC1 or related proteins, thus enhancing ENC1's activity. Similarly, Phorbol 12-myristate 13-acetate (PMA) and Isoproterenol enhance ENC1's functionality by activating protein kinase C (PKC) and beta-adrenergic receptors respectively, which are known to engage in cross-talk with signaling pathways that ENC1 may be a part of. Ionomycin raises intracellular calcium levels, possibly affecting calcium-dependent proteins that interact with ENC1, leading to its enhanced function. Sodium orthovanadate, by inhibiting protein tyrosine phosphatases, and Epigallocatechin gallate (EGCG), known to affect kinase activity, might increase phosphorylation within ENC1's signaling pathways, thus indirectly increasing ENC1 activity.
Furthermore, PI3K inhibitor LY294002 could alter the AKT signaling pathway, affecting the functional activity of ENC1 indirectly. Phosphatase inhibitors such as Okadaic Acid and Calyculin A are presumed to increase the phosphorylation state within the cellular milieu, which could potentially enhance the activity of ENC1 by modifying the proteins it interacts with. Sphingosine-1-phosphate (S1P) engages with G-protein-coupled receptors to orchestrate a myriad of signaling pathways, potentially intersecting with those modulated by ENC1, leading to an enhanced role of ENC1 in signal transduction. Anisomycin, although a protein synthesis inhibitor, activates stress-activated protein kinases, which could influence ENC1 functionality by modulating related signaling pathways. Collectively, these compounds are posited to enhance the functional activity of ENC1 by influencing the phosphorylation patterns and signaling environments that ENC1 is involved in, without directly increasing its expression levels or requiring direct binding to ENC1.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels within cells. Elevated cAMP activates PKA, which can then phosphorylate various targets, potentially including ENC1, or proteins that interact with ENC1, thus enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC phosphorylation can lead to a cascade of events within the cellular signaling pathways that might enhance the functional activity of ENC1 by modulating its phosphorylation state. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore which increases intracellular calcium levels. Elevated calcium can activate calcium-dependent signaling pathways, which could indirectly enhance the functional activity of ENC1 by influencing its interaction with other proteins. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is an inhibitor of protein tyrosine phosphatases. By preventing dephosphorylation, it could enhance the phosphorylation state of proteins in signaling pathways potentially involving ENC1, thereby enhancing its functional activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that can diffuse into cells and mimic the effects of cAMP. Similar to Forskolin, it can activate PKA, potentially enhancing the functional activity of ENC1 by influencing phosphorylation events within its signaling pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to have various effects on signal transduction pathways, including inhibition of certain kinases. This modulation could lead to altered phosphorylation patterns that might enhance the functional activity of ENC1 indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, it can alter downstream signaling pathways such as AKT, which may have cross-talk with ENC1 signaling, leading to the enhancement of ENC1's activity through indirect modulation of its signaling environment. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of various proteins. This could indirectly enhance ENC1 functional activity by altering the phosphorylation landscape ENC1 operates within. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, Calyculin A inhibits phosphatases, particularly PP1 and PP2A, which could lead to an enhanced phosphorylation state of ENC1 or associated proteins, indirectly increasing ENC1's functional activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, leading to activation of PKA. This can enhance the phosphorylation state of proteins involved in the same signaling pathways as ENC1, potentially enhancing its activity. | ||||||